The Boston area has seen a lot of hospital merger and acquisition activity in recent years, some of it successful, some not. Now two not-for-profit health plans are merging, chasing the same goal of scaling up and reducing costs through streamlining administrative processes. Tufts Health Plan and Harvard Pilgrim Health Care, both based in the […]
After a nearly two-year hiatus, the diagnostic and therapeutic imaging giant Siemens Healthineers AG (XETRA: SHL.DE) has agreed to purchase Corindus Vascular Robotics, Inc. (NYSE: CVRS) for $1.1 billion, at a price of $4.28 per share. Corindus is a global leader in robotic-assisted vascular interventions. Its CorPath platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary […]
This past week Permira, a global investment firm based in the United Kingdom, spent $2.4 billion for Cambrex Corporation (NYSE: CBM). Cambrex is a premier contract development and manufacturing organization (CDMO) in the small molecule space and provides drug substance, drug product and analytical services across the entire drug lifecycle. The $2.4 billion purchase price includes the company’s […]
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]
After a slow first quarter, deal volume picked up again in the second. Pundits predicted a strong end to 2019, but the preliminary results from July’s deal making seem to indicate otherwise. With 126 transactions reported, July 2019’s deal volume sagged 17% compared with June’s and 18% against the same month in 2018. You may […]
It’s hard to imagine where health care would be today without private equity firms. Since 2013, merger and acquisition activity in all healthcare sectors has soared 80%, to a record 1,908 deals announced in 2018. Private equity sponsors accounted for approximately 32% of those transactions, both direct and add-ons. Of the $333.3 billion spent last […]
Cantel Medical Corp. (NYSE: CMD) acquired another medical device company last week, Hu-Friedy Mfg. Co., LLC. The target company has a long history as a dental instrument manufacturer, providing instrument reprocessing workflow systems that have served the dental industry for over 111 years. Cantel agreed to pay $725 million upfront, $60 million of which will be paid in Cantel stock […]
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]
It’s official. Pfizer Inc. (NYSE: PFE) will spin off Upjohn, its off-patent branded and generic drug division, and merge it with another generic drug maker, Mylan N.V. (NASDAQ: MYL), to create a new company. The deal is structured as an all-stock Reverse Morris Trust merger. Pfizer shareholders will own 57% of the new combined company, […]
Almost two years ago, in September 2017, Bain Capital Private Equity acquired cloud-based revenue cycle management (RCM) company ZirMed for a reported $750 million and merged it with its own revenue cycle management company, Navicure. The combination formed Waystar, which integrated ZirMed’s business and clinical performance management solutions with Navicure’s own cloud-based RCM platform that focused on medical […]
